
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 5
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 5
Showing 5 citing articles:
Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 978-978
Open Access
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 978-978
Open Access
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials
Y. Wang, Zonglin Li, Chu Lin, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Y. Wang, Zonglin Li, Chu Lin, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Clinical Variables that Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy
Shinnosuke Okubo, Akinobu Takaki, Ikumi Sato, et al.
Internal Medicine (2025)
Open Access
Shinnosuke Okubo, Akinobu Takaki, Ikumi Sato, et al.
Internal Medicine (2025)
Open Access
Evaluating the Effectiveness of Pegbelfermin in MASH ‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials
Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access